Invites Biocore Co., Ltd. (XKON:216400)
South Korea · Delayed Price · Currency is KRW 4,090.00
-40.00 (-0.97%)
At close: Feb 13, 2026
Invites Biocore Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2014 | FY 2013 | FY 2008 | FY 2007 | FY 2006 |
|---|---|---|---|---|---|
Period Ending | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 |
Operating Revenue | 16,956 | 13,108 | 10,668 | 12,777 | 8,644 |
Other Revenue | 0 | - | - | - | 0 |
| 16,956 | 13,108 | 10,668 | 12,777 | 8,644 | |
Revenue Growth (YoY) | 29.35% | 22.88% | -16.51% | 47.82% | 67.31% |
Cost of Revenue | 13,330 | 9,879 | 9,479 | 9,749 | 7,193 |
Gross Profit | 3,626 | 3,229 | 1,189 | 3,028 | 1,451 |
Selling, General & Admin | 1,854 | 1,698 | 1,874 | 1,980 | 1,428 |
Research & Development | 498.48 | 470.5 | 1,524 | 645.75 | 700.3 |
Amortization of Goodwill & Intangibles | 4.35 | 5.2 | 3.8 | 21.33 | 72.12 |
Other Operating Expenses | 43.2 | 35.81 | 24.83 | 25.86 | 16.2 |
Operating Expenses | 2,424 | 2,224 | 3,417 | 2,773 | 2,295 |
Operating Income | 1,202 | 1,005 | -2,229 | 255.12 | -844.69 |
Interest Expense | -171.67 | -201.06 | -228.28 | -193.75 | -110.71 |
Interest & Investment Income | 8.79 | 4.6 | 13.56 | 21.09 | 23.79 |
Earnings From Equity Investments | - | - | -64.25 | 19.66 | -27.21 |
Currency Exchange Gain (Loss) | 9.85 | 3.37 | 46.23 | 0.84 | -6.12 |
Other Non Operating Income (Expenses) | -391.39 | 0.32 | -83.87 | 52.75 | -117.45 |
EBT Excluding Unusual Items | 657.45 | 812.4 | -2,545 | 155.7 | -1,082 |
Gain (Loss) on Sale of Investments | - | - | 19.11 | 115.13 | -6.64 |
Gain (Loss) on Sale of Assets | 10.18 | -0.6 | -13.04 | -55.31 | 0.04 |
Other Unusual Items | - | - | 18.55 | - | - |
Pretax Income | 667.63 | 811.8 | -2,521 | 215.51 | -1,089 |
Income Tax Expense | - | - | - | - | 19.74 |
Net Income | 667.63 | 811.8 | -2,521 | 215.51 | -1,109 |
Net Income to Common | 667.63 | 811.8 | -2,521 | 215.51 | -1,109 |
Net Income Growth | -17.76% | - | - | - | - |
Shares Outstanding (Basic) | 4 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 2 | 2 | 2 | 2 |
Shares Change (YoY) | 87.69% | -0.10% | 0.34% | -0.46% | 0.02% |
EPS (Basic) | 163.00 | 372.00 | -1154.00 | 99.00 | -507.00 |
EPS (Diluted) | 163.00 | 372.00 | -1154.00 | 99.00 | -507.00 |
EPS Growth | -56.18% | - | - | - | - |
Free Cash Flow | 1,712 | 283.34 | 841.51 | -2,362 | -86.11 |
Free Cash Flow Per Share | 417.87 | 129.84 | 385.25 | -1084.87 | -39.38 |
Gross Margin | 21.39% | 24.63% | 11.14% | 23.70% | 16.78% |
Operating Margin | 7.09% | 7.67% | -20.89% | 2.00% | -9.77% |
Profit Margin | 3.94% | 6.19% | -23.63% | 1.69% | -12.83% |
Free Cash Flow Margin | 10.09% | 2.16% | 7.89% | -18.48% | -1.00% |
EBITDA | 1,730 | 1,401 | -924.86 | 1,304 | -91.18 |
EBITDA Margin | 10.21% | 10.69% | -8.67% | 10.20% | -1.05% |
D&A For EBITDA | 528.41 | 395.6 | 1,304 | 1,049 | 753.51 |
EBIT | 1,202 | 1,005 | -2,229 | 255.12 | -844.69 |
EBIT Margin | 7.09% | 7.67% | -20.89% | 2.00% | -9.77% |
Advertising Expenses | 17.68 | 19.12 | 68.05 | 12.86 | 7.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.